Liver Transplant Clinical Trial
Official title:
Randomized Controlled Clinical Trial Of Stented Versus Stentless Biliary Anastomosis In Living Donor Liver Transplantation
| Verified date | May 2020 |
| Source | Minia University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Determination of biliary complications in stented group compared to duct to duct anastomosis without stent
| Status | Completed |
| Enrollment | 30 |
| Est. completion date | November 10, 2019 |
| Est. primary completion date | November 10, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 60 Years |
| Eligibility |
Inclusion Criteria: - adult patients eligible for a liver transplantation - patients' written informed consent signed. Exclusion Criteria: - biliary reconstruction requires a hepatico-jejunostomy for anatomical/biliary disease reason. |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Air force spcialized hospital | Cairo |
| Lead Sponsor | Collaborator |
|---|---|
| Alaa Mstafa Hassan Sewefy | Ain Shams University |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | skeletonization of duct | skeletonization of duct | 10 hours | |
| Primary | biliary complications after living donor liver transplantation | incidence of biliary complications after living donor liver transplantation | one year | |
| Secondary | biliary complications | types of biliary complications | one year | |
| Secondary | biliary related mortality | mortality | one year | |
| Secondary | rate of cholangitis | rate of cholangitis | 3 months | |
| Secondary | hospital stay | hospital stay | one month | |
| Secondary | time 2 biliary complications | time 2 biliary complications | one year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02798861 -
Controlled Attenuation Parameter (CAP) in Liver Allografts
|
||
| Completed |
NCT03527238 -
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
|
Phase 2 | |
| Completed |
NCT01696331 -
Text Messaging for Adherence in Adolescent Liver Transplant Recipients
|
N/A | |
| Recruiting |
NCT05051605 -
Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
|
||
| Recruiting |
NCT05940857 -
Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry
|
||
| Completed |
NCT01598987 -
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
|
Phase 3 | |
| Active, not recruiting |
NCT05074160 -
OCS Liver Perfusion (OLP) Post-Approval Registry
|
||
| Completed |
NCT05087550 -
Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation
|
||
| Recruiting |
NCT04836923 -
LIFT Intervention in Liver Transplant Candidates
|
N/A | |
| Not yet recruiting |
NCT03666689 -
Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation
|
||
| Not yet recruiting |
NCT06088758 -
Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool
|
N/A | |
| Terminated |
NCT01230502 -
Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation
|
N/A | |
| Completed |
NCT00171509 -
Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients
|
Phase 4 | |
| Not yet recruiting |
NCT06254248 -
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
|
Phase 2 | |
| Recruiting |
NCT06075745 -
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
|
Phase 2 | |
| Completed |
NCT02057484 -
A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
|
||
| Active, not recruiting |
NCT03577431 -
Liver Transplantation With Tregs at MGH
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06342557 -
Transitional ePRO Diary Liver
|
||
| Not yet recruiting |
NCT04265157 -
Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant
|
||
| Recruiting |
NCT02863250 -
Australian and New Zealand Massive Transfusion Registry
|